Efficacy and Safety of Long-Term Losartan Therapy Demonstrated by a Prospective Observational Study in Japanese Patients with Hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) Study
Open Access
- 1 January 2008
- journal article
- research article
- Published by Japanese Society of Hypertension in Hypertension Research
- Vol. 31 (2) , 295-304
Abstract
The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study is a nationwide, prospective, multicentered, observational study that was designed to enroll 30,000 hypertensive Japanese patients from more than 3,000 private practitioners. It is the first large-scale observational study to assess the efficacy and safety of losartan, an angiotensin II receptor antagonist, in Japan. Patients were enrolled between June 2000 and May 2002, and followed up to June 2005. The data from 29,850 patients were used for the analysis of safety and efficacy. These patients were treated with losartan mostly at a daily dose of 25–50 mg. The mean follow-up period was 2.9 years. The patients were aged 62.4±12.1 years (mean±SD) and their mean systolic/diastolic blood pressure was 165.3±17.2/94.3±11.7 mmHg (mean±SD). Mean blood pressure in patients who were evaluated for efficacy decreased from 165.8/94.8 mmHg (n=26,512) at baseline to 145.5/84.4 mmHg after 3 months (n=21,269) and 138.6/80.0 mmHg after 36 months of treatment (n=13,879). Blood pressure was well controlled during the study period by losartan alone or losartan-based combination therapy. In nearly half of the patients, blood pressure was reduced to less than 140/90 mmHg during the study period. In addition to its antihypertensive effect, losartan reduced the uric acid level in patients whose baseline uric acid level was ≥7 mg/dL. Losartan also prevented acceleration of proteinuria. Adverse drug reactions occurred in 1,081 of the 29,850 patients. Long-term losartan therapy was effective and well tolerated in Japanese clinical practice.Keywords
This publication has 35 references indexed in Scilit:
- Design and Baseline Characteristics of an Observational Study in Japanese Patients with Hypertension: Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH)Hypertension Research, 2007
- Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL studyClinical and Experimental Nephrology, 2006
- Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004)Hypertension Research, 2006
- High prevalence and poor control of hypertension in primary careJournal Of Hypertension, 2004
- Hypertension Treatment and Control in Five European Countries, Canada, and the United StatesHypertension, 2004
- Renoprotective Effect of Losartan in Comparison to Amlodipine in Patients with Chronic Kidney Disease and Hypertension-a Report of the Japanese Losartan Therapy Intended for the Global Renal Protection Hypertensive Patients (JLIGHT) StudyHypertension Research, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertensionJournal Of Hypertension, 2003
- Prognostic Significance of Renal Function in Elderly Patients with Isolated Systolic HypertensionJournal of the American Society of Nephrology, 2002
- Cardiovascular epidemiology in the Asia-Pacific regionAsia Pacific Journal of Clinical Nutrition, 2001